The coming months are expected to inform recommendations from the F.D.A., with the agency already receiving a prototype for a JN.1-targeted vaccine from Moderna that is expected to be tested in people starting in September.
Dr. Peter Marks, who oversees that division, urged the committee to consider encouraging the mRNA vaccine makers to focus on the latest versions of the virus in broader circulation.
#fda-advisory-committee #covid-vaccine-formula-update #jn1-variant #fall-immunization-campaign #mrna-vaccines
[
Collection
]
[
|
...
]